The Institute of Food Technologists Annual Meeting and Food Expo is a premier event for professionals in the food science and technology industries. It's an opportunity to explore the latest innovations and network with industry leaders.
This annual event is significant for keeping food industry professionals abreast of the latest technological developments and scientific research. Attendees can expect to gain valuable insights through engaging keynote addresses, participate in interactive workshops, and explore cutting-edge innovations in food technology. The event also serves as a platform for discussing challenges and opportunities within the industry, focusing on sustainability, safety, and regulatory compliance.
What you will learn
Latest trends in food innovation.
Cutting-edge research in food science.
Networking with industry experts.
Regulatory updates and compliance.
Emerging food safety practices.
Want to exhibit at this event?
MarketScale can act as a third-party concierge, helping you request exhibitor packages, pricing, and booth availability. No cold calls, no commitment.
Key Highlights
• Keynote speeches from pioneering food scientists.
• Workshops on sustainable food production.
• Panels on food safety advancements.
• Exhibitions showcasing novel food technologies.
Frequently asked questions
Topics & tracks
MarketScale platform
Exhibiting at this event?
Capture customer testimonials onsite, with your iPhone.
Record quick customer interviews at your booth or in the aisle. MarketScale turns each one into a produced video, written article, and social clips.
Learn how →sciences articles
Biopharma's $300 Billion Problem Is Driving the Biggest M&A Cycle in a Decade
More than $300 billion in branded pharmaceutical revenue faces patent expiration by 2030. Big Pharma cannot replace it through internal R&D alone. The result is the most aggressive acquisition cycle since before the pandemic, and it is reshaping how the entire life sciences supply chain does business.
Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic
Quotient Sciences initiates what it calls the first Phase I trial of an AI-designed oral drug formulation, approved by the UK's MHRA.
Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic
Quotient Sciences has initiated a Phase I study of an AI-designed oral formulation, cleared by the MHRA—marking a concrete shift from AI experimentation to clin
MarketScale
MarketScale helps B2B teams cover events like this and turn them into content their market reads. Want to talk through what that looks like?